Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
71.23
-0.39 (-0.55%)
At close: Jun 12, 2026, 4:00 PM EDT
71.53
+0.30 (0.42%)
After-hours: Jun 12, 2026, 7:36 PM EDT
Liquidia Market Cap
Liquidia has a market cap or net worth of $6.33 billion as of June 12, 2026. Its market cap has increased by 394.00% in one year.
Market Cap
6.33B
Enterprise Value
6.30B
1-Year Change
394.00%
Ranking
Category
Stock Price
$71.23
Market Cap Chart
Since July 26, 2018, Liquidia's market cap has increased from $167.77M to $6.33B, an increase of 3,675.52%. That is a compound annual growth rate of 58.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 6.33B | 111.11% |
| Dec 31, 2025 | 3.00B | 201.46% |
| Dec 31, 2024 | 995.33M | 20.97% |
| Dec 29, 2023 | 822.82M | 100.28% |
| Dec 30, 2022 | 410.83M | 62.30% |
| Dec 31, 2021 | 253.13M | 98.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 16.45B |
| Elanco Animal Health | 11.40B |
| Dr. Reddy's Laboratories | 11.14B |
| Regencell Bioscience Holdings | 9.83B |
| Alkermes | 7.44B |
| Lantheus Holdings | 6.67B |
| Hims & Hers Health | 6.50B |
| Amneal Pharmaceuticals | 5.02B |